In addition, to our knowledge, we discovered for the first time that KRAS mutations constitute a powerful and independent predictive tIRPS in Qujing populations with advanced NSCLC not treated with ICIs. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.